MedicalXpress.com – Vaccines

A new multi-state study led by the Centers for Disease Control and Prevention’s (CDC) VISION Network—including Regenstrief Institute—has provided the most comprehensive assessment to date of the effectiveness of 2023–2024 COVID-19 vaccines among adults in […]

The world has made unprecedented progress in vaccinating children against life-threatening diseases since WHO established the Expanded Program on Immunization (EPI) in 1974. Despite the progress of the past 50 years, the last two decades […]

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.This post was originally published on this site

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly enhance their effectiveness. […]

Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants—materials that help stimulate the immune […]

A vaccine developed by University of Georgia researchers successfully protects against and treats vaginal yeast infections in mice, according to a newly published study in npj Vaccines.This post was originally published on this site

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants.This post was originally published on this site

In the quest to design vaccines that better help the body’s immune system fight disease, scientists are always looking for more tools for their arsenal.This post was originally published on this site

A new multinational study analyzing data from over 230 million people across 20 global sites highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barré syndrome (GBS). This research reinforces the importance of continuous […]

A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.This post was originally published on this site